NCT03031392

Brief Summary

Bleeding on probing demonstrated to have high specificity with certain level of sensitivity to detect periodontal disease. Again, understanding the weak hemidesmosome attachment to the implant surface is imperative to discern on the probe penetration extent and subsequent bleeding. In the presence of inflammation, bleeding should be present indicating high sensitivity when probing deeper sites; nevertheless the lack thereof in healthy condition does not seem to translate high specificity. In this sense, it is noteworthy to mention that the mucogingival shift after implant placement often decreases the presence of keratinized mucosa, triggering a greater inflammatory condition on the peri-implant tissues. Thereupon, bleeding on probing, although might reliably indicate presence of disease, it does not seem to be a suitable diagnostic parameter. On the other side, suppuration characterizes the necrosis of peri-implant tissues, being rich in polymorphonuclear cells and as such, a sensitive indicator of bone turnover. In this sense, it must be noted that, if detected in early stages where bone resorption has not occurred yet, it might be a consequence of a foreign body reaction (i.e., residual cement or floss). Therefore, in the diagnosis of peri-implantitis, radiographic examination must be always incorporated to the clinical assessment as the 'gold standard'. Hence, the aim of this case-control study was to assess the diagnostic accuracy of peri-implantitis-related clinical parameters compared to otherwise healthy dental implants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
141

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 25, 2017

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 2, 2017

Completed
Last Updated

May 11, 2017

Status Verified

January 1, 2017

Enrollment Period

9 months

First QC Date

January 20, 2017

Last Update Submit

May 10, 2017

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sensitivity to detect peri-implantitis

    Capability to diagnose disease

    1 year

  • Specificity to detect peri-implantitis

    Capability to diagnose health

    1 year

Study Arms (2)

Peri-implantitis

Individuals with implants ≥2mm of radiographic bone loss

Diagnostic Test: Sensitivity test

non-peri-implantitis patients

Individuals with implants \<2mm of radiographic bone loss

Diagnostic Test: Sensitivity test

Interventions

Sensitivity testDIAGNOSTIC_TEST

Routine clinical and radiographic examination

Peri-implantitisnon-peri-implantitis patients

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients will be either approached during their biannual peri-implant maintenance recall appointment or contacted and asked to participate in a free clinical and radiographic examination to identify the possible presence of peri-implant pathology.

You may qualify if:

  • patients within the age range of 18 to 80,
  • non- or light smokers (\<10cigarettes/day),
  • no presence of infectious diseases at the time of implant placement or during the maintenance program,
  • no presence of serious disease or condition known to alter bone metabolism,
  • partial edentulous patients with stable periodontal condition with or without history of chronic periodontitis.

You may not qualify if:

  • pregnancy,
  • history of heavy smoking,
  • uncontrolled medical conditions such as diabetes mellitus,
  • not adequate implant position (i.e., prosthetically driven),
  • not properly restored impeding accurate probing depth recording
  • lack of keratinized mucosa

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro de Implantologia Cirugia Oral y Maxiofacial

Badajoz, 06001, Spain

Location

MeSH Terms

Conditions

HypersensitivityPeri-Implantitis

Condition Hierarchy (Ancestors)

Immune System DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Officials

  • Florencio Monje Gil

    Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 20, 2017

First Posted

January 25, 2017

Study Start

July 1, 2016

Primary Completion

April 1, 2017

Study Completion

April 2, 2017

Last Updated

May 11, 2017

Record last verified: 2017-01

Data Sharing

IPD Sharing
Will not share

Locations